|
Special Offer in Joint Venture
Tagalder Biotech Project
Jan 8, 2003
Tagalder thorough its associated companies have been working with
Medical Services Inc. and Niumanchiang
Bioengineering Incubator Co., Ltd. in the biotech
development. Tagalder also adds another new partner, Inno Biotech Inc.
to this list.
Tagalder is working with its partners in the following
technology areas. Tagalder can provide consulting and
laboratory services in the biotechnologies.
- Generic antibody drugs such as anti-cancer, RT arthritis
treatment. We have the techniques and expression system for
humanization and production of these drugs.
- Diagnostic kit and devices: we have the techniques and
reagents for disease such as stoke, HIV diagnosis. We also
developed a technique platform for rapid assay.
- HIV gp-120 expression system that could be developed
into vaccine production.
- Patented anti-oxidants purification methods for
extracting anti-cancer and anti-ageing products such as
lycopene from plants.
- Drug delivery system through lung.
- Drug abuse vaccine and catalytic therapeutic antibody
development.
- Customized cancer immunotherapy and vaccine development
platform.
- Cancer suppress gene and its potential application.
- Generic synthetic peptide drugs and vaccines.
For further information, please contact
biotech@tagalder.com
|
